The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Combination therapies for combating antimicrobial resistance
Open accessAbstract
New drug development strategies are needed to combat antimicrobial resistance. The object of this perspective is to highlight one such strategy: treating infections with sets of drugs rather than individual drugs. We will highlight three categories of combination therapy: those that inhibit targets in different pathways; those that inhibit distinct nodes in the same pathway; and those that inhibit the very same target in different ways. We will then consider examples of naturally occurring combination therapies produced by microorganisms, and conclude by discussing key opportunities and challenges for making more widespread use of drug combinations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotics for Emerging Pathogens
Fischbach, M. A., & Walsh, C. T. (2009) · Science · doi:10.1126/science.1176667 · Cited by 1,777
Self-citationSampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594
The antibiotic resistome: the nexus of chemical and genetic diversity
Wright, G. D. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1614 · Cited by 1,365
Artemisinins target the SERCA of Plasmodium falciparum
Eckstein-Ludwig, U., Webb, R. J., van Goethem, I. D. A., East, J. M., Lee, A. G., Kimura, M., O'Neill, P. M., Bray, P. G., Ward, S. A., & Krishna, S. (2003) · Nature · doi:10.1038/nature01813 · Cited by 1,027
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
Allison, K. R., Brynildsen, M. P., & Collins, J. J. (2011) · Nature · doi:10.1038/nature10069 · Cited by 1,025
Ōmura, S., Ikeda, H., Ishikawa, J., Hanamoto, A., Takahashi, C., Shinose, M., Takahashi, Y., Horikawa, H., Nakazawa, H., Osonoe, T., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211433198 · Cited by 801
Antibiotics: Actions, Origins, Resistance
Walsh, C. T. (2003) · Medical Entomology and Zoology · Cited by 675
Glycopeptide and Lipoglycopeptide Antibiotics
Kahne, D., Leimkuhler, C., Lu, W., & Walsh, C. (2005) · Chemical Reviews · doi:10.1021/cr030103a · Cited by 662
Lennox, J. L., DeJesus, E., Lazzarin, A., Pollard, R. B., Madruga, J. V. R., Berger, D. S., Zhao, J., Xu, X., Williams-Diaz, A., Rodgers, A. J., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60918-1 · Cited by 625
New antibiotics from bacterial natural products
Clardy, J., Fischbach, M. A., & Walsh, C. T. (2006) · Nature Biotechnology · doi:10.1038/nbt1266 · Cited by 615
Self-citationChallis, G. L., & Hopwood, D. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934677100 · Cited by 597
Genome Sequence of the Streptomycin-Producing Microorganism Streptomyces griseus IFO 13350
Ohnishi, Y., Ishikawa, J., Hara, H., Suzuki, H., Ikenoya, M., Ikeda, H., Yamashita, A., Hattori, M., & Horinouchi, S. (2008) · Journal of Bacteriology · doi:10.1128/jb.00204-08 · Cited by 563
Dysregulation of bacterial proteolytic machinery by a new class of antibiotics
Brötz-Oesterhelt, H., Beyer, D., Kroll, H.-P., Endermann, R., Ladel, C., Schroeder, W., Hinzen, B., Raddatz, S., Paulsen, H., Henninger, K., et al. (2005) · Nature Medicine · doi:10.1038/nm1306 · Cited by 505
An Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II
Hasper, H. E., Kramer, N. E., Smith, J. L., Hillman, J. D., Zachariah, C., Kuipers, O. P., de Kruijff, B., & Breukink, E. (2006) · Science · doi:10.1126/science.1129818 · Cited by 501
Targeting Tyrosine Kinases in Cancer: The Second Wave
Baselga, J. (2006) · Science · doi:10.1126/science.1125951 · Cited by 478
Antibiotic interactions that select against resistance
Chait, R., Craney, A., & Kishony, R. (2007) · Nature · doi:10.1038/nature05685 · Cited by 439
Tu, D., Blaha, G., Moore, P. B., & Steitz, T. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.005 · Cited by 433
Richman, D. D. (2001) · Nature · doi:10.1038/35073673 · Cited by 419
Oliynyk, M., Samborskyy, M., Lester, J. B., Mironenko, T., Scott, N., Dickens, S., Haydock, S. F., & Leadlay, P. F. (2007) · Nature Biotechnology · doi:10.1038/nbt1297 · Cited by 402
Hansen, J. L., Moore, P. B., & Steitz, T. A. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00668-5 · Cited by 393
Drug interactions and the evolution of antibiotic resistance
Yeh, P. J., Hegreness, M. J., Aiden, A. P., & Kishony, R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2133 · Cited by 350
Antibiotics of the virginiamycin family, inhibitors which contain synergistic components
COCITO, C. G. (1979) · Microbiological Reviews · doi:10.1128/mr.43.2.145-192.1979 · Cited by 327
The evolution of gene collectives: How natural selection drives chemical innovation
Fischbach, M. A., Walsh, C. T., & Clardy, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709132105 · Cited by 309
Self-citationAccelerated evolution of resistance in multidrug environments
Hegreness, M., Shoresh, N., Damian, D., Hartl, D., & Kishony, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805965105 · Cited by 300
Expanding the soil antibiotic resistome: exploring environmental diversity
D’Costa, V. M., Griffiths, E., & Wright, G. D. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.08.009 · Cited by 287
Challenges in tuberculosis drug research and development
Ginsberg, A. M., & Spigelman, M. (2007) · Nature Medicine · doi:10.1038/nm0307-290 · Cited by 283
Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis
Sacchettini, J. C., Rubin, E. J., & Freundlich, J. S. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1816 · Cited by 256
A single amino acid residue can determine the sensitivity of SERCAs to artemisinins
Uhlemann, A.-C., Cameron, A., Eckstein-Ludwig, U., Fischbarg, J., Iserovich, P., Zuniga, F. A., East, M., Lee, A., Brady, L., Haynes, R. K., et al. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb947 · Cited by 256
Combination drugs, an emerging option for antibacterial therapy
Cottarel, G., & Wierzbowski, J. (2007) · Trends in Biotechnology · doi:10.1016/j.tibtech.2007.09.004 · Cited by 237
Nonoptimal microbial response to antibiotics underlies suppressive drug interactions
Bollenbach, T., Quan, S., Chait, R., & Kishony, R. (2009) · Cell · doi:10.1016/j.cell.2009.10.025 · Cited by 227
Structures of ClpP in complex with acyldepsipeptide antibiotics reveal its activation mechanism
Lee, B.-G., Park, E. Y., Lee, K.-E., Jeon, H., Sung, K. H., Paulsen, H., Rübsamen-Schaeff, H., Brötz-Oesterhelt, H., & Song, H. K. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1787 · Cited by 226
Drug interactions modulate the potential for evolution of resistance
Michel, J.-B., Yeh, P. J., Chait, R., Moellering, R. C., & Kishony, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800944105 · Cited by 215
Antibiotics: Natural products essential to human health
Demain, A. L. (2009) · Medicinal Research Reviews · doi:10.1002/med.20154 · Cited by 208
Antimicrobial agents: antibacterials and antifungals.
Bryskier, A. (2005) · Cited by 173
Malaria as a Reemerging Disease
Krostad, D. J. (1996) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017918 · Cited by 153
HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review
Bierman, W. F. W., van Agtmael, M. A., Nijhuis, M., Danner, S. A., & Boucher, C. A. (2009) · AIDS · doi:10.1097/qad.0b013e32831c54e5 · Cited by 152
Biosynthetic Gene Cluster of Simocyclinone, a Natural Multihybrid Antibiotic
Trefzer, A. C., Pelzer, S., Schimana, J., Stockert, S., Bihlmaier, C., Fiedler, H., Welzel, K., Vente, A., & Bechthold, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1174-1182.2002 · Cited by 116
Simocyclinone D8, an Inhibitor of DNA Gyrase with a Novel Mode of Action
Flatman, R. H., Howells, A. J., Heide, L. E., Fiedler, H., & Maxwell, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1093-1100.2005 · Cited by 115
Wormser, G. P., Keusch, G. T., & Heel, R. C. (1982) · Drugs · doi:10.2165/00003495-198224060-00002 · Cited by 114
Ward, J. M., & Hodgson, J. E. (1993) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1993.tb06326.x · Cited by 113
Clinical Role of ??-Lactam/??-Lactamase Inhibitor Combinations
Lee, N. L. S., Yuen, K., & Kumana, C. R. (2003) · Drugs · doi:10.2165/00003495-200363140-00006 · Cited by 100
Chemical decay of an antibiotic inverts selection for resistance
Palmer, A. C., Angelino, E. L., & Kishony, R. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.289 · Cited by 91
A Crystal Structure of the Bifunctional Antibiotic Simocyclinone D8, Bound to DNA Gyrase
Edwards, M. J., Flatman, R. H., Mitchenall, L. A., Stevenson, C. E. M., Le, T. B. K., Clarke, T. A., McKay, A. R., Fiedler, H., Buttner, M. J., Lawson, D. M., et al. (2009) · Science · doi:10.1126/science.1179123 · Cited by 90
Alexander, D. C., & Jensen, S. E. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.16.4068-4079.1998 · Cited by 87
Resolution of Gene Regulatory Conflicts Caused by Combinations of Antibiotics
Bollenbach, T., & Kishony, R. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.016 · Cited by 45
Cited by
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Antibiotic resistance: a rundown of a global crisis
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173867 · Cited by 2,552
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Wong, D., Nielsen, T. B., Bonomo, R. A., Pantapalangkoor, P., Luna, B., & Spellberg, B. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-16 · Cited by 1,170
The global threat of antimicrobial resistance: science for intervention.
Roca, I., Akova, M., Baquero, F., Carlet, J., Cavaleri, M., Coenen, S., Cohen, J., Findlay, D., Gyssens, I., Heure, O. E., et al. (2015) · New Microbes and New Infections · doi:10.1016/j.nmni.2015.02.007 · Cited by 1,106
Metadata
- Authors
- Fischbach, M. A.
- Venue
- Current Opinion in Microbiology
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 14
- Issue
- 5
- Pages
- 519-523
- ISSN
- 1369-5274 (ISSN-L)
- OpenAlex
- W2014069105
- Cited by
- 259
- References
- 45
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.